Tonix Pharmaceuticals Holding Corp. (TNXP)
3.01
-0.23
(-7.10%)
USD |
NASDAQ |
Nov 13, 16:00
3.06
+0.05
(+1.66%)
After-Hours: 19:59
Tonix Pharmaceuticals Total Assets (Quarterly) : 242.43M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 242.43M |
| June 30, 2026 | 254.09M |
| March 31, 2026 | 257.91M |
| December 31, 2025 | 277.17M |
| September 30, 2025 | 252.44M |
| June 30, 2025 | 187.36M |
| March 31, 2025 | 192.87M |
| December 31, 2024 | 162.89M |
| September 30, 2024 | 94.99M |
| June 30, 2024 | 70.31M |
| March 31, 2024 | 135.34M |
| December 31, 2023 | 154.46M |
| September 30, 2023 | 139.28M |
| June 30, 2023 | 159.74M |
| March 31, 2023 | 179.09M |
| December 31, 2022 | 225.69M |
| September 30, 2022 | 242.65M |
| June 30, 2022 | 276.16M |
| March 31, 2022 | 223.72M |
| December 31, 2021 | 240.90M |
| September 30, 2021 | 214.77M |
| June 30, 2021 | 189.16M |
| March 31, 2021 | 183.52M |
| December 31, 2020 | 98.18M |
| September 30, 2020 | 67.62M |
| Date | Value |
|---|---|
| June 30, 2020 | 58.34M |
| March 31, 2020 | 33.93M |
| December 31, 2019 | 14.56M |
| September 30, 2019 | 12.27M |
| June 30, 2019 | 15.01M |
| March 31, 2019 | 20.02M |
| December 31, 2018 | 26.32M |
| September 30, 2018 | 16.06M |
| June 30, 2018 | 18.36M |
| March 31, 2018 | 20.98M |
| December 31, 2017 | 26.75M |
| September 30, 2017 | 30.54M |
| June 30, 2017 | 35.82M |
| March 31, 2017 | 23.78M |
| December 31, 2016 | 27.51M |
| September 30, 2016 | 29.80M |
| June 30, 2016 | 34.32M |
| March 31, 2016 | 31.35M |
| December 31, 2015 | 47.02M |
| September 30, 2015 | 57.82M |
| June 30, 2015 | 50.93M |
| March 31, 2015 | 60.47M |
| December 31, 2014 | 39.54M |
| September 30, 2014 | 47.33M |
| June 30, 2014 | 45.06M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Heron Therapeutics, Inc. | 230.45M |
| Ionis Pharmaceuticals, Inc. | 2.913B |
| TG Therapeutics, Inc. | 1.592B |
| Karyopharm Therapeutics, Inc. | 111.32M |
| Minerva Neurosciences, Inc. | 98.28M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 42.94M |
| Shareholders Equity (Quarterly) | 199.48M |
| Debt to Equity Ratio | 0.0063 |
| Current Ratio | 4.572 |
| Net Debt Paydown Yield | -0.08% |